Pharmaceutical companies patent the drugs they make and position themselves in a monopolistic manner to corner the target market of their product leaving no lower cost alternatives to the consumer keeping costs extremely high. Eventually, however, that patent will expire.
In 2011, along with Eli Lilly's, Zyprexa, Pfizer's Lipitor patent expired creating the opportunity for companies to manufacture a product with the same ingredients and set their own prices.
Click here for generic Lipitor with no prior prescription necessary!
In 2012, 12 more patents are set to expire bringing more opportunities for consumer's to choose how they purchase medication, in turn, driving prices drastically lower! 2 more to come in 2013. advantagemedicalonline.com has capitalized on a majority of these expirations already and generics are available already!!!
So, what medications are they?
| Patent ends | Brand name | Generic name | Use/conditions treated | Made/sold by |
| March 2012 | Lexapro | escitalopram | depression | Forest/Labs |
| March 2012 | Seroquel | quetiapine | schizophrenia/bipolar | AstraZeneca |
| March 2012 | Avapro/Avalide | irbesartan | high blood pressure | Bristol-Myers/Sanofi |
| April 2012 | Provigil | modafinil | narcolepsy | Cephalon |
| May 2012 | Plavix | clopidogrel | clot prevention | Bristol-Myers/Sanofi |
| July 2012 | Tricor | fenofibrate | high triglycerides | Abbott |
| Aug. 2012 | Singulair | montelukast | asthma/allergies | Merck |
| Aug. 2012 | Actos | pioglitazone | diabetes | Takeda |
| Sept. 2012 | Diovan | valsartan | high blood pressure | Novartis |
| Sept. 2012 | Geodon | ziprasidone | bipolar disorder | Pfizer |
| Nov. 2012 | Lidoderm | lidocaine | pain patch | Endo |
| Dec. 2012 | Atacand | candesartan | heart failure | AstraZeneca |
| March 2013 | Lovaza | omega-3 acid | high triglycerides | GlaxoSmithKline |
| Aug. 2013 | Temodar | temozolomide | brain tumors | Merck |
| Note: Patent expiration/generic arrival dates can change due to litigation or regulatory issues. | ||||
